AstraZeneca PLC (AZN)
184.49
+0.11
(+0.06%)
USD |
NYSE |
Nov 13, 16:00
184.32
-0.17
(-0.09%)
After-Hours: 17:51
AstraZeneca Market Cap : 572.23B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 571.89B |
| November 11, 2026 | 575.30B |
| November 10, 2026 | 579.27B |
| November 09, 2026 | 587.42B |
| November 06, 2026 | 578.24B |
| November 05, 2026 | 579.55B |
| November 04, 2026 | 586.25B |
| November 03, 2026 | 570.33B |
| November 02, 2026 | 578.71B |
| October 30, 2026 | 578.93B |
| October 29, 2026 | 540.93B |
| October 28, 2026 | 525.76B |
| October 27, 2026 | 527.53B |
| October 26, 2026 | 533.67B |
| October 23, 2026 | 531.90B |
| October 22, 2026 | 535.25B |
| October 21, 2026 | 522.48B |
| October 20, 2026 | 523.62B |
| October 19, 2026 | 508.52B |
| October 16, 2026 | 513.05B |
| October 15, 2026 | 516.99B |
| October 14, 2026 | 502.56B |
| October 13, 2026 | 483.30B |
| October 12, 2026 | 491.09B |
| October 09, 2026 | 493.79B |
| Date | Value |
|---|---|
| October 08, 2026 | 492.48B |
| October 07, 2026 | 496.64B |
| October 06, 2026 | 491.96B |
| October 05, 2026 | 485.50B |
| October 02, 2026 | 486.65B |
| October 01, 2026 | 489.13B |
| September 30, 2026 | 500.83B |
| September 29, 2026 | 509.32B |
| September 28, 2026 | 515.34B |
| September 25, 2026 | 516.68B |
| September 24, 2026 | 510.41B |
| September 23, 2026 | 506.60B |
| September 22, 2026 | 522.23B |
| September 21, 2026 | 521.39B |
| September 18, 2026 | 515.12B |
| September 17, 2026 | 515.31B |
| September 16, 2026 | 505.23B |
| September 15, 2026 | 502.00B |
| September 14, 2026 | 507.99B |
| September 11, 2026 | 496.79B |
| September 10, 2026 | 495.15B |
| September 09, 2026 | 486.78B |
| September 08, 2026 | 496.39B |
| September 04, 2026 | 504.64B |
| September 03, 2026 | 511.06B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GSK Plc | 101.16B |
| Johnson & Johnson | 688.44B |
| Eli Lilly & Co. | 1.360T |
| Merck & Co., Inc. | 364.44B |
| Novo Nordisk A/S | 139.36B |
Market Cap Related Metrics
| PS Ratio | 9.524 |
| PEG Ratio | 1.629 |
| Price to Book Value | 12.09 |
| Price to Free Cash Flow | 71.54 |
| Price | 184.49 |
| Earnings Yield | 1.80% |
| PEGY Ratio | 1.550 |
| Operating PE Ratio | 41.00 |
| Normalized PE Ratio | 54.77 |